EMVision Medical Devices (EMV.AX) Earnings Analysis
EMVision Medical Devices (EMV.AX) next reports earnings on 2026-09-02. Trailing P/E -13.83.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EMV.AX next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
EMV.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-23 | -0.0445 AUD | n/a | n/a | n/a |
| 2025-07-31 | -0.07299 AUD | n/a | n/a | n/a |
| 2025-02-26 | -0.04179 AUD | n/a | n/a | n/a |
| 2024-10-30 | -0.03155 AUD | n/a | n/a | n/a |
EMV.AX valuation and analyst view
| Trailing P/E | -13.83 |
|---|---|
| Trailing EPS | -0.11441 AUD |
| Price / book | 7.34 |
| Dividend yield | 0.00% |
| Market cap | 0.15B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is EMVision Medical Devices (EMV.AX)'s next earnings date?
EMVision Medical Devices is next scheduled to report on 2026-09-02.
Did EMV.AX beat earnings last quarter?
Consensus estimate data was not available for EMV.AX's 2026-02-23 report.
What is EMV.AX's current P/E ratio and EPS?
EMV.AX trades at a trailing P/E of -13.83 on trailing EPS of -0.11441475409766197 AUD.
What do analysts rate EMV.AX?
EMV.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.